By David Wild
Initial findings from the American Gastroenterological Association Fecal Microbiota Transplantation National Registry show that the procedure is 90% effective in treating recurrent Clostridioides difficile infection at one month, and is associated with a modest 6% rate of serious adverse events.
“This is the largest prospective study to date of effectiveness and safety outcomes after FMT,” Colleen Kelly, MD, of the Warren Alpert Medical School of Brown University, in